IL231007A0 - Means and methods for estimating toxicity related to blood cell formation - Google Patents
Means and methods for estimating toxicity related to blood cell formationInfo
- Publication number
- IL231007A0 IL231007A0 IL231007A IL23100714A IL231007A0 IL 231007 A0 IL231007 A0 IL 231007A0 IL 231007 A IL231007 A IL 231007A IL 23100714 A IL23100714 A IL 23100714A IL 231007 A0 IL231007 A0 IL 231007A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- hematopoietic toxicity
- assessing
- assessing hematopoietic
- toxicity
- Prior art date
Links
- 230000003394 haemopoietic effect Effects 0.000 title 1
- 230000001988 toxicity Effects 0.000 title 1
- 231100000419 toxicity Toxicity 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/709—Toxin induced
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161533867P | 2011-09-13 | 2011-09-13 | |
| EP11181156 | 2011-09-13 | ||
| PCT/IB2012/054731 WO2013038341A1 (en) | 2011-09-13 | 2012-09-12 | Means and methods for assessing hematopoietic toxicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL231007A0 true IL231007A0 (en) | 2014-03-31 |
Family
ID=47882692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL231007A IL231007A0 (en) | 2011-09-13 | 2014-02-17 | Means and methods for estimating toxicity related to blood cell formation |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20150037825A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2756301A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2014526681A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20140059805A (cg-RX-API-DMAC7.html) |
| CN (2) | CN106053832A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012310147A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014005472A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2845621A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL231007A0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013038341A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114594192A (zh) * | 2022-03-07 | 2022-06-07 | 山东大学 | 一种泊沙康唑起始物料中氯苯胺和氯硝基苯胺同分异构体的检测方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7112409B2 (en) * | 1999-01-29 | 2006-09-26 | Center For Molecular Medicine And Immunology | Method of determining cytokine dosage for myelosuppressive state |
| JP2003245076A (ja) * | 2001-01-30 | 2003-09-02 | Takeda Chem Ind Ltd | 新規タンパク質およびそのｄｎａ |
| CA2496251A1 (en) * | 2002-08-21 | 2004-03-04 | Ivan N. Rich | High-throughput assay of hematopoietic stem and progenitor cell proliferation |
| US20040121305A1 (en) * | 2002-12-18 | 2004-06-24 | Wiegand Roger Charles | Generation of efficacy, toxicity and disease signatures and methods of use thereof |
| US8034613B2 (en) * | 2005-06-01 | 2011-10-11 | Wisconsin Alumni Research Foundation | Multipotent lymphohematopoietic progenitor cells |
| US8563253B2 (en) * | 2006-08-30 | 2013-10-22 | Metanomics Gmbh | Means and method for diagnosing hemolytic anemia |
| US7689187B2 (en) * | 2007-03-01 | 2010-03-30 | Motorola, Inc. | Dual input low noise amplifier for multi-band operation |
| US8062222B2 (en) * | 2007-06-13 | 2011-11-22 | Litron Laboratories, Ltd. | Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment |
| DE112009001234T5 (de) * | 2008-05-28 | 2011-04-28 | Basf Se | Mittel und Verfahren zur Abschätzung von Lebertoxizität |
-
2012
- 2012-09-12 JP JP2014529131A patent/JP2014526681A/ja active Pending
- 2012-09-12 EP EP12832241.9A patent/EP2756301A4/en not_active Withdrawn
- 2012-09-12 WO PCT/IB2012/054731 patent/WO2013038341A1/en not_active Ceased
- 2012-09-12 CN CN201610422742.2A patent/CN106053832A/zh active Pending
- 2012-09-12 US US14/344,517 patent/US20150037825A1/en not_active Abandoned
- 2012-09-12 AU AU2012310147A patent/AU2012310147A1/en not_active Abandoned
- 2012-09-12 BR BR112014005472A patent/BR112014005472A2/pt not_active IP Right Cessation
- 2012-09-12 CN CN201280044690.XA patent/CN103827667B/zh not_active Expired - Fee Related
- 2012-09-12 CA CA2845621A patent/CA2845621A1/en not_active Abandoned
- 2012-09-12 KR KR1020147006461A patent/KR20140059805A/ko not_active Withdrawn
-
2014
- 2014-02-17 IL IL231007A patent/IL231007A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103827667A (zh) | 2014-05-28 |
| EP2756301A4 (en) | 2015-08-12 |
| WO2013038341A1 (en) | 2013-03-21 |
| US20150037825A1 (en) | 2015-02-05 |
| AU2012310147A1 (en) | 2014-03-13 |
| JP2014526681A (ja) | 2014-10-06 |
| CA2845621A1 (en) | 2013-03-21 |
| BR112014005472A2 (pt) | 2017-03-28 |
| CN106053832A (zh) | 2016-10-26 |
| EP2756301A1 (en) | 2014-07-23 |
| KR20140059805A (ko) | 2014-05-16 |
| CN103827667B (zh) | 2016-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2721179A4 (en) | BIOMARKER COMPOSITIONS AND ASSOCIATED METHODS | |
| PT2731451T (pt) | Métodos e composições para produtos de consumo | |
| EP2736330A4 (en) | COMPOUNDS AND METHODS | |
| GB201105474D0 (en) | Testing apparatus | |
| EP2747560A4 (en) | CONNECTIONS AND METHODS | |
| EP2736332A4 (en) | CONNECTIONS AND METHODS | |
| IL232634A0 (en) | Kits and methods for evaluating appendicitis | |
| EP2736329A4 (en) | COMPOUNDS AND METHODS | |
| ZA201400562B (en) | Axmi205 variant proteins and methods for their use | |
| GB201118773D0 (en) | Probe | |
| GB201110783D0 (en) | Methods and uses | |
| GB2481487B (en) | Amplifier | |
| GB201122089D0 (en) | Telecomunication apparatus and methods | |
| GB201116131D0 (en) | Probe | |
| GB201120991D0 (en) | Microsensor | |
| GB201116774D0 (en) | Uses and methods | |
| GB2487998B (en) | Amplifier | |
| PL2691770T3 (pl) | Prekoncentrator | |
| IL230937A0 (en) | Means and methods for estimating renal toxicity | |
| GB201411762D0 (en) | Precoating methods and compositions | |
| GB2489262B (en) | Testing apparatus | |
| ZA201308892B (en) | Compositions and methods | |
| AU342348S (en) | Testing apparatus | |
| GB201120989D0 (en) | Genetic test | |
| GB201105569D0 (en) | Apparatus and methods |